Compare Anupam Rasayan with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.75%
- Poor long term growth as Operating profit has grown by an annual rate 18.86% of over the last 5 years
Flat results in Jun 26
With ROCE of 8, it has a Very Expensive valuation with a 3.2 Enterprise value to Capital Employed
Stock DNA
Specialty Chemicals
INR 13,714 Cr (Small Cap)
79.00
25
0.00%
0.44
5.10%
4.04
Total Returns (Price + Dividend) 
Latest dividend: 1.5 per share ex-dividend date: Sep-18-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Anupam Rasayan India Ltd is Rated Strong Sell
Anupam Rasayan India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 19 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Anupam Rasayan India Ltd is Rated Strong Sell
Anupam Rasayan India Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 September 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Anupam Rasayan India Ltd Technical Momentum Shifts Amid Bearish Signals
Anupam Rasayan India Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish outlook. Despite a strong long-term return profile, recent technical parameters suggest caution for investors as the stock’s momentum deteriorates.
Read full news article Announcements 
Board Meeting Outcome for Outcome Of Board Meeting Held On September 17 2026.
17-Sep-2026 | Source : BSEOutcome of Board Meeting - Approval for execution of certain security documents.
Board Meeting Intimation for Fund Raising By Way Of Issuance Of Secured Rated Unlisted Redeemable Non-Convertible Debentures On Private Placement Basis
16-Sep-2026 | Source : BSEAnupam Rasayan India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2026 inter alia to consider and approve the fund raising of up to INR 1600000000/- (Indian Rupees One Hundred Sixty Crore Only) by way of issuance of Secured Rated Unlisted Redeemable Non-Convertible Debentures on Private Placement basis
Announcement under Regulation 30 (LODR)-Newspaper Publication
09-Sep-2026 | Source : BSESubmission of Newspaper Advertisement regarding 23rd Annual General Meeting of the members of the Company.
Corporate Actions 
(19 Sep 2026)
Anupam Rasayan India Ltd has declared 15% dividend, ex-date: 18 Sep 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
21.792
Held by 17 Schemes (0.19%)
Held by 67 FIIs (7.71%)
Kiran Pallavi Investments Llc (31.8%)
Milan R Thakkar (14.41%)
23.23%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is 3.02% vs 24.07% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is -9.40% vs -13.03% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 122.06% vs -29.59% in Sep 2024
Growth in half year ended Sep 2025 is 280.91% vs -74.03% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 84.34% vs -12.64% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 161.32% vs -50.07% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 64.61% vs -2.58% in Mar 2025
YoY Growth in year ended Mar 2026 is 82.24% vs -27.41% in Mar 2025






